McCarthy C - Search Results

1

[Measurement of quality of life in intermittent claudication. Clinical validation of a questionnaire].

Marquis P, Fayol C, McCarthy C, Fiessinger JN. Marquis P, et al. Among authors: mccarthy c. Presse Med. 1994 Sep 24;23(28):1288-92. Presse Med. 1994. PMID: 7984525 French.

2

[Quality of life of women with stress urinary incontinence with or without pollakiuria].

Amarenco G, Marquis P, McCarthy C, Richard F. Amarenco G, et al. Among authors: mccarthy c. Presse Med. 1998 Jan 10;27(1):5-10. Presse Med. 1998. PMID: 9767753 Clinical Trial. French.

3

[Elaboration and validation of a specific quality of life questionnaire for urination urgency in women].

Marquis P, Amarenco G, Sapède C, Josserand F, McCarthy C, Zerbib M, Richard F, Jacquetin B, Villet R, Leriche B, Casanova JM, Conquy S, Zafiropoulos M. Marquis P, et al. Among authors: mccarthy c. Prog Urol. 1997 Feb;7(1):56-63. Prog Urol. 1997. PMID: 9116740 French.

4

[Development and validation of a quality of life scale associated with health status, specific for benign hypertrophy of the prostate and including a sexuality evaluation scale].

Lukacs B, McCarthy C, Leplege A, Comet D. Lukacs B, et al. Among authors: mccarthy c. Prog Urol. 1994 Oct;4(5):688-99. Prog Urol. 1994. PMID: 7532071 French.

5

Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,093 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General Practice.

Lukacs B, McCarthy C, Grange JC. Lukacs B, et al. Among authors: mccarthy c. Eur Urol. 1993;24 Suppl 1:34-40. doi: 10.1159/000474372. Eur Urol. 1993. PMID: 7687557 Clinical Trial.

6

[Prospective follow-up of 3,228 patients suffering from clinical benign prostatic hyperplasia (BPH) treated for 3 years wi alfuzosin in general practice. BPH Group in General Practice].

Lukacs B, Grange JC, Comet D, Mc Carthy C. Lukacs B, et al. Prog Urol. 1999 Apr;9(2):271-80. Prog Urol. 1999. PMID: 10370951 Clinical Trial. French.

7

PREVENTing Hypertensive Cardiovascular Disease: Where to Draw the Line?

McCarthy CP, McEvoy JW, Brown JM. McCarthy CP, et al. J Am Coll Cardiol. 2025 Oct 28;86(17):1449-1451. doi: 10.1016/j.jacc.2025.08.053. J Am Coll Cardiol. 2025. PMID: 41125319 No abstract available.

8

Potentially inappropriate prescribing and falls-risk increasing drugs in people who have experienced a fall: a systematic review and meta-analysis.

O'Reilly T, Gómez Lemus J, Booth L, Clyne B, McCarthy C, Ibrahim K, Thompson W, McAuliffe C, Moriarty F. O'Reilly T, et al. Among authors: mccarthy c. Age Ageing. 2025 Aug 29;54(10):afaf300. doi: 10.1093/ageing/afaf300. Age Ageing. 2025. PMID: 41118395 Free PMC article.

9

Rare Lung Diseases: Expanding Horizons in Pathogenesis, Diagnosis, and Care.

McCarthy C, Gupta N. McCarthy C, et al. Clin Chest Med. 2025 Dec;46(4):xi-xii. doi: 10.1016/j.ccm.2025.09.001. Epub 2025 Sep 25. Clin Chest Med. 2025. PMID: 41110934 No abstract available.

10

Neuroendocrine Hyperplasia of Infancy and Diffuse Idiopathic Neuroendocrine Cell Hyperplasia: Two Faces of Pulmonary Neuroendocrine Cell Pathology.

Worrell JC, O'Brien H, Quinn S, Pabary R, Murphy DJ, Fabre A, Byrne AJ, McCarthy C. Worrell JC, et al. Among authors: mccarthy c. Clin Chest Med. 2025 Dec;46(4):727-738. doi: 10.1016/j.ccm.2025.07.011. Epub 2025 Sep 1. Clin Chest Med. 2025. PMID: 41110932 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,980 results

Search Page

Filters